These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8956013)

  • 1. Pathophysiology of sickle cell anemia.
    Bookchin RM; Lew VL
    Hematol Oncol Clin North Am; 1996 Dec; 10(6):1241-53. PubMed ID: 8956013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solidity of sickle hemoglobin gels: relevance to pathophysiology of sickling disorders.
    Danish EH; Harris JW; Oh K
    Cleve Clin J Med; 1989; 56(8):793-800. PubMed ID: 2605778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte Hb-S concentration. An important factor in the low oxygen affinity of blood in sickle cell anemia.
    Seakins M; Gibbs WN; Milner PF; Bertles JF
    J Clin Invest; 1973 Feb; 52(2):422-32. PubMed ID: 4683881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmotic effects of protein polymerization: analysis of volume changes in sickle cell anemia red cells following deoxy-hemoglobin S polymerization.
    Lew VL; Bookchin RM
    J Membr Biol; 1991 May; 122(1):55-67. PubMed ID: 1875401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alpha-thalassemia-2 on the developmental changes of hematological values in children with sickle cell disease from Georgia.
    Felice AE; McKie KM; Cleek MP; Marino EM; Kutlar A; McKie VC
    Am J Hematol; 1987 Aug; 25(4):389-400. PubMed ID: 2441597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 2, 3-diphosphoglycerate on the solubility of deoxy-sickle hemoglobin.
    Swerdlow PH; Bryan RA; Bertles JF; Poillon WN; Magdoff-Fairchild B; Milner PF
    Hemoglobin; 1977; 1(6):527-37. PubMed ID: 914634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing haemoglobin oxygen affinity to prevent sickling: abnormal haemoglobin variants as models.
    Franklin IM; Huehns ER; Rosemeyer MA
    Br J Haematol; 1986 Oct; 64(2):319-29. PubMed ID: 3778826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular hemoglobin S polymerization and the clinical severity of sickle cell anemia.
    Poillon WN; Kim BC; Castro O
    Blood; 1998 Mar; 91(5):1777-83. PubMed ID: 9473246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell disease: the proportion of liganded haemoglobin needed to prevent crises.
    Franklin IM; Rosemeyer MA; Huehns ER
    Br J Haematol; 1983 Aug; 54(4):579-87. PubMed ID: 6871109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea and erythropoietin therapy in sickle cell anemia.
    Goldberg MA; Brugnara C; Dover GJ; Schapira L; Lacroix L; Bunn HF
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):74-81. PubMed ID: 1379376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of carbon dioxide and pH variations in vitro on blood respiratory functions, red blood cell volume, transmembrane pH gradients, and sickling in sickle cell anemia.
    Ueda Y; Bookchin RM
    J Lab Clin Med; 1984 Aug; 104(2):146-59. PubMed ID: 6431043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of oxygen transport and cardiac index for the prevention of sickle cell crises.
    Farrell K; Dent L; Nguyen ML; Buchowski M; Bhatt A; Aguinaga Mdel P
    J Natl Med Assoc; 2010 Nov; 102(11):1000-7. PubMed ID: 21141287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of sickle cell anemia with hydroxyurea and erythropoietin.
    Goldberg MA; Brugnara C; Dover GJ; Schapira L; Charache S; Bunn HF
    N Engl J Med; 1990 Aug; 323(6):366-72. PubMed ID: 1695325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell disease and nitric oxide: a paradigm shift?
    Mack AK; Kato GJ
    Int J Biochem Cell Biol; 2006; 38(8):1237-43. PubMed ID: 16517208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia.
    Bookchin RM; Ortiz OE; Lew VL
    J Clin Invest; 1991 Jan; 87(1):113-24. PubMed ID: 1702096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous polymerization and adhesion under hypoxia in sickle cell disease.
    Papageorgiou DP; Abidi SZ; Chang HY; Li X; Kato GJ; Karniadakis GE; Suresh S; Dao M
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9473-9478. PubMed ID: 30190429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of sickle cell anemia by iron-limited erythropoiesis.
    Castro O; Poillon WN; Finke H; Massac E
    Am J Hematol; 1994 Oct; 47(2):74-81. PubMed ID: 7522396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of F-reticulocytes in sickle cell disease.
    Horiuchi K; Osterhout ML; Ohene-Frempong K
    Biochem Biophys Res Commun; 1995 Dec; 217(3):924-30. PubMed ID: 8554617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.